Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2020

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Schedule of Fair Value of Derivative Instruments

The location and fair values of derivative instruments designated as hedging instruments in the Condensed Consolidated Balance Sheets as of September 30, 2020, are shown in the following table:

	As of
	September 30,			December 31,
	2020			2019
Interest rate swaps reported in Other current assets	$	—		$	82
Interest rate swaps reported in Accrued liabilities	$	(671	)	$	—
Interest rate swaps reported in Other long-term obligations	$	(1,789	)	$	(78	)
Foreign currency hedges reported in Other current assets	$	—		$	580
Foreign currency hedges reported in Accrued liabilities	$	(615	)	$	—

Summary of Derivative Instruments, Gain (Loss)

The effect of derivative instruments on the Condensed Consolidated Statements of Earnings is as follows:

	Three Months Ended					Nine Months Ended
	September 30,			September 30,		September 30,			September 30,
	2020			2019		2020			2019
Foreign Exchange Contracts:
Amounts reclassified from AOCI to earnings:
Net sales	$	(78	)	$	—	$	(5	)	$	—
Cost of goods sold		(407	)		286		(678	)		562
Selling, general and administrative expense		—			23		(5	)		62
Total (loss) gain reclassified from AOCI to earnings		(485	)		309		(688	)		624
Gain recognized in other expense for hedge ineffectiveness		—			—		3			—
Total derivative (loss) gain on foreign exchange contracts recognized in earnings	$	(485	)	$	309	$	(685	)	$	624
Interest Rate Swaps:
(Expense) benefit recorded in Interest expense	$	(171	)	$	117	$	(242	)	$	430
Total (losses) gains on derivatives	$	(656	)	$	426	$	(927	)	$	1,054